Details for Patent: 11,154,513
✉ Email this page to a colleague
Which drugs does patent 11,154,513 protect, and when does it expire?
Patent 11,154,513 protects VEVYE and is included in one NDA.
This patent has thirty-two patent family members in fourteen countries.
Drugs Protected by US Patent 11,154,513
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | VEVYE | cyclosporine | SOLUTION;OPHTHALMIC | 217469-001 | May 30, 2023 | RX | Yes | Yes | 11,154,513 | ⤷ Subscribe | Y | TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED) | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,154,513
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016329261 | ⤷ Subscribe | |||
| Australia | 2020205239 | ⤷ Subscribe | |||
| Australia | 2022200366 | ⤷ Subscribe | |||
| Canada | 2998269 | ⤷ Subscribe | |||
| China | 108349855 | ⤷ Subscribe | |||
| China | 110693825 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
